Loading...

The global impact of Precision Medicine Group.
As it happens.

Impact, observations, and insights on the evolving healthcare landscape.

Key Takeaways: World EPA Congress 2022

2022-05-17T10:19:09-04:00Cell & Gene Therapy, Events|

Did you miss our presentation at this year’s World EPA Congress in Amsterdam? Precision experts Richard Macaulay (VP, Global Pricing and Market Access) and David Carr (Director, Global Pricing and Market Access) presented “Gene Therapies Market Access: Lessons From The Past, Future Best Practice” which analyzes the access success of launched gene therapies and draws best-practice learnings for future gene therapies.

(more…)

On-Demand Webinar: Planning for the Commercialization of Advanced Therapies

2022-03-25T11:47:34-04:00Cell & Gene Therapy, Events|

In January, the Alliance for Regenerative Medicine (ARM) released its State of the Industry Briefing which highlighted a record-breaking year for 2021. $23.1B raised for the advanced medicines sector (a 16% increase from 2020), 2,261 ongoing regenerative medicine clinical trials globally, and the evolution from treating and curing rare monogenetic diseases to more prevalent indications. Could we see 10-20 approvals each year by 2025?

(more…)

On-Demand Webinar: CQV Strategies that Increase Speed-to-Market for Gene Therapy

2021-12-17T10:29:58-05:00Cell & Gene Therapy, Events|

To successfully increase speed-to-market for gene therapies, having a defined CQV (Commissioning, Qualification, and Validation) strategy is critical to project success. In this webinar co-sponsored by Precision ADVANCE and Project Farma, our panel of industry experts discuss tips for delivering efficient, reliable, GMP-compliant facilities and processes specific to gene therapy.

(more…)

On-Demand Webinar: State of the Union for Advanced Medicines

2021-12-09T10:08:29-05:00Cell & Gene Therapy, Events|

We are in the midst of a therapeutic revolution. An H1 report released by Alliance for Regenerative Medicine (ARM) highlights a record-breaking year, with over 1,320 ongoing clinical trials worldwide and 1000+ therapeutic developers. As 2021 comes to an end, we are on track to expect the highest number of advanced therapy regulatory approvals, when compared to previous years.

(more…)

On-Demand Webinar: CQV Strategies to Optimize Cell Therapy Manufacturing

2021-12-03T09:18:33-05:00Cell & Gene Therapy, Events|

When building a cell therapy manufacturing facility, having a defined CQV (Commissioning, Qualification, and Validation) strategy is critical to project success. In this webinar co-sponsored by Precision ADVANCE and Project Farma, our panel of industry experts discuss tips for delivering efficient, reliable, GMP-compliant facilities and processes specific to cell therapy.

(more…)

On-Demand Webinar: Scaling Up a Gene Therapy Manufacturing Facility

2021-11-02T18:16:56-04:00Cell & Gene Therapy, Events|

Scaling up a gene therapy manufacturing facility is extremely complex and challenging. In this webinar, co-sponsored by Precision ADVANCE and Project Farma, a panel of industry experts discuss the strategies and challenges faced when building a cutting-edge gene therapy facility from the planning stages to build-out to operational readiness. They will also share key insights into their company’s approach to building these facilities and for mitigating risk under accelerated timelines.

(more…)

Load More Posts